menu
    • menu

    Company profile for Enanta Pharmaceuticals

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Enanta’s chemistry-driven approach and drug discovery capabilities is focused on small molecule drugs for the treatment of viral infections and liver diseases such as respiratory syncytial virus (RSV), non-alcoholic steatohepatitis (NASH)/ primary biliary cholangitis (PBC), and hepatitis B virus (HBV). Enanta has selected EDP-514, an inhibitor of the HBV core protein as its first clinical candidate which is now in a Phase 1 ...
    Enanta’s chemistry-driven approach and drug discovery capabilities is focused on small molecule drugs for the treatment of viral infections and liver diseases such as respiratory syncytial virus (RSV), non-alcoholic steatohepatitis (NASH)/ primary biliary cholangitis (PBC), and hepatitis B virus (HBV). Enanta has selected EDP-514, an inhibitor of the HBV core protein as its first clinical candidate which is now in a Phase 1 clinical study.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Enanta PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Enanta Pharmaceuticals, Inc. Headquarters 500 Arsenal Street Watertown, MA 024...
    Telephone
    Telephone
    (617) 607-0800
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    --
    Linkedin
    Linkedin
    https://in.linkedin.com/company/enanta-pharmaceuticals
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/EnantaPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enanta Pharma Reveals Fiscal Q4 & Full-Year 2025 Financials
    Enanta Pharma Reveals Fiscal Q4 & Full-Year 2025 Financials

    17 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251117823831/en/Enanta-Pharmaceuticals-Reports-Financial-Results-for-its-Fiscal-Fourth-Quarter-and-Year-Ended-September-30-2025

    BUSINESSWIRE
    17 Nov 2025
    Share Share
    Enanta Pharma To Join Investor Conferences
    Enanta Pharma To Join Investor Conferences

    04 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251104405023/en/Enanta-Pharmaceuticals-to-Participate-in-Upcoming-Investor-Conferences

    BUSINESSWIRE
    04 Nov 2025
    Share Share
    Enanta Pharma Unveils Zelicapavir And EDP-323, Data For RSV
    Enanta Pharma Unveils Zelicapavir And EDP-323, Data For RSV

    20 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251020795690/en/Enanta-Pharmaceuticals-Presents-New-Data-for-Zelicapavir-its-N-Protein-Inhibitor-and-EDP-323-its-L-Protein-Inhibitor-Both-in-Development-for-the-Treatment-of-Respiratory-Syncytial-Virus-RSV-at-IDWeek-2025

    BUSINESSWIRE
    20 Oct 2025
    Share Share
    Enanta To Present Zelicapavir, EDP-323 RSV Data At IDWeek 2025
    Enanta To Present Zelicapavir, EDP-323 RSV Data At IDWeek 2025

    07 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-07/enanta-pharmaceuticals-to-present-data-for-zelicapavir-and-edp-323-two-candidates-in-development-fo

    PHARMIWEB
    07 Oct 2025
    Share Share
    Enanta Pharma Closes Oversubscribed Stock Offering
    Enanta Pharma Closes Oversubscribed Stock Offering

    02 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251002172271/en/Enanta-Pharmaceuticals-Announces-Closing-of-Upsized-Public-Offering-of-Common-Stock-Including-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares

    BUSINESSWIRE
    02 Oct 2025
    Share Share
    Enanta's RSVTreatment Helps Speed up Recovery in Study
    Enanta's RSVTreatment Helps Speed up Recovery in Study

    30 Sep 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/enantas-rsv-treatment-misses-main-goal-mid-stage-study-2025-09-29/

    REUTERS
    30 Sep 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search